FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078804807> ?p ?o ?g. }

• W2078804807 endingPage "1515" @default.
• W2078804807 startingPage "1511" @default.
• W2078804807 abstract "Whether nebulized ipratropium bromide is of benefit to mechanically ventilated patients with chronic bronchitis is not well defined. The objective of the study was to determine the effect of ipratropium bromide as a nebulized solution on ventilatory function in patients with severe airflow limitation and under ventilator treatment because of respiratory failure. The design was a randomized, double-blind, controlled trial. Forty-two ventilated patients (43 to 83 years old) with acute airflow obstruction and wheezing or coughing were chosen. The patients were randomly allocated to treatment every 6 h with either 500 μg of nebulized ipratropium bromide or 0.9 percent saline solution. Comparison was made between ipratropium bromide and placebo. Their responses were assessed in terms of arterial blood gas analysis, pulmonary mechanics, and respiratory symptoms. No significant differences in oxygenation, arterial CO2 tension, or static lung compliance attributable to ipratropium were found. However, a significant tendency to decreased mean airway resistance, peak inspiratory pressure, mean airway pressure, and improved symptom status 24 h after giving ipratropium was observed. We conclude that ventilated patients with obstructive lung disease could obtain incremental benefit from adding nebulized ipratropium to aminophylline. Their responses may be explained by the bronchodilating effect of ipratropium that resulted in a reduced airway resistance and a lower mean airway pressure. Whether nebulized ipratropium bromide is of benefit to mechanically ventilated patients with chronic bronchitis is not well defined. The objective of the study was to determine the effect of ipratropium bromide as a nebulized solution on ventilatory function in patients with severe airflow limitation and under ventilator treatment because of respiratory failure. The design was a randomized, double-blind, controlled trial. Forty-two ventilated patients (43 to 83 years old) with acute airflow obstruction and wheezing or coughing were chosen. The patients were randomly allocated to treatment every 6 h with either 500 μg of nebulized ipratropium bromide or 0.9 percent saline solution. Comparison was made between ipratropium bromide and placebo. Their responses were assessed in terms of arterial blood gas analysis, pulmonary mechanics, and respiratory symptoms. No significant differences in oxygenation, arterial CO2 tension, or static lung compliance attributable to ipratropium were found. However, a significant tendency to decreased mean airway resistance, peak inspiratory pressure, mean airway pressure, and improved symptom status 24 h after giving ipratropium was observed. We conclude that ventilated patients with obstructive lung disease could obtain incremental benefit from adding nebulized ipratropium to aminophylline. Their responses may be explained by the bronchodilating effect of ipratropium that resulted in a reduced airway resistance and a lower mean airway pressure." @default.
• W2078804807 created "2016-06-24" @default.
• W2078804807 creator A5037012206 @default.
• W2078804807 creator A5050041360 @default.
• W2078804807 creator A5073956211 @default.
• W2078804807 date "1994-05-01" @default.
• W2078804807 modified "2023-10-18" @default.
• W2078804807 title "Nebulized Ipratropium Bromide in Ventilator-assisted Patients With Chronic Bronchitis" @default.
• W2078804807 cites W151474171 @default.
• W2078804807 cites W1942076457 @default.
• W2078804807 cites W1983126850 @default.
• W2078804807 cites W1994508688 @default.
• W2078804807 cites W2000880651 @default.
• W2078804807 cites W2001331807 @default.
• W2078804807 cites W2007534485 @default.
• W2078804807 cites W2018072332 @default.
• W2078804807 cites W2040047181 @default.
• W2078804807 cites W2050513982 @default.
• W2078804807 cites W2053518757 @default.
• W2078804807 cites W2053670674 @default.
• W2078804807 cites W2062131199 @default.
• W2078804807 cites W2076368004 @default.
• W2078804807 cites W2130255350 @default.
• W2078804807 cites W2135132941 @default.
• W2078804807 cites W2135817135 @default.
• W2078804807 cites W2139719460 @default.
• W2078804807 cites W2159831296 @default.
• W2078804807 cites W2278197958 @default.
• W2078804807 cites W2280607089 @default.
• W2078804807 cites W2332228509 @default.
• W2078804807 cites W2390804623 @default.
• W2078804807 cites W2414135532 @default.
• W2078804807 cites W2415307223 @default.
• W2078804807 cites W2772528085 @default.
• W2078804807 doi "https://doi.org/10.1378/chest.105.5.1511" @default.
• W2078804807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8181345" @default.
• W2078804807 hasPublicationYear "1994" @default.
• W2078804807 type Work @default.
• W2078804807 sameAs 2078804807 @default.
• W2078804807 citedByCount "16" @default.
• W2078804807 countsByYear W20788048072012 @default.
• W2078804807 countsByYear W20788048072021 @default.
• W2078804807 crossrefType "journal-article" @default.
• W2078804807 hasAuthorship W2078804807A5037012206 @default.
• W2078804807 hasAuthorship W2078804807A5050041360 @default.
• W2078804807 hasAuthorship W2078804807A5073956211 @default.
• W2078804807 hasConcept C105922876 @default.
• W2078804807 hasConcept C126322002 @default.
• W2078804807 hasConcept C2776042228 @default.
• W2078804807 hasConcept C2780532441 @default.
• W2078804807 hasConcept C2781018748 @default.
• W2078804807 hasConcept C2909577894 @default.
• W2078804807 hasConcept C2992694001 @default.
• W2078804807 hasConcept C33362165 @default.
• W2078804807 hasConcept C42219234 @default.
• W2078804807 hasConcept C71924100 @default.
• W2078804807 hasConceptScore W2078804807C105922876 @default.
• W2078804807 hasConceptScore W2078804807C126322002 @default.
• W2078804807 hasConceptScore W2078804807C2776042228 @default.
• W2078804807 hasConceptScore W2078804807C2780532441 @default.
• W2078804807 hasConceptScore W2078804807C2781018748 @default.
• W2078804807 hasConceptScore W2078804807C2909577894 @default.
• W2078804807 hasConceptScore W2078804807C2992694001 @default.
• W2078804807 hasConceptScore W2078804807C33362165 @default.
• W2078804807 hasConceptScore W2078804807C42219234 @default.
• W2078804807 hasConceptScore W2078804807C71924100 @default.
• W2078804807 hasIssue "5" @default.
• W2078804807 hasLocation W20788048071 @default.
• W2078804807 hasLocation W20788048072 @default.
• W2078804807 hasOpenAccess W2078804807 @default.
• W2078804807 hasPrimaryLocation W20788048071 @default.
• W2078804807 hasRelatedWork W155470709 @default.
• W2078804807 hasRelatedWork W1988797668 @default.
• W2078804807 hasRelatedWork W2050513982 @default.
• W2078804807 hasRelatedWork W2056237273 @default.
• W2078804807 hasRelatedWork W2078804807 @default.
• W2078804807 hasRelatedWork W2081835439 @default.
• W2078804807 hasRelatedWork W2117006167 @default.
• W2078804807 hasRelatedWork W2135132941 @default.
• W2078804807 hasRelatedWork W2413044408 @default.
• W2078804807 hasRelatedWork W2738827351 @default.
• W2078804807 hasVolume "105" @default.
• W2078804807 isParatext "false" @default.
• W2078804807 isRetracted "false" @default.
• W2078804807 magId "2078804807" @default.
• W2078804807 workType "article" @default.